Literature DB >> 22818904

Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.

Kyoko Fujita1, Kei Shinoda, Yutaka Imamura, Celso Soiti Matsumoto, Yoshihiro Mizutani, Atsushi Mizota, Mitsuko Yuzawa.   

Abstract

PURPOSE: To investigate the relationship between the integrity of the photoreceptor microstructures and retinal sensitivity after half-dose photodynamic therapy (PDT) in eyes with chronic central serous chorioretinopathy (CSC).
DESIGN: Prospective, noncomparative, interventional case series.
METHODS: Thirteen eyes of 13 patients with chronic CSC who had received half-dose verteporfin PDT were studied. The best-corrected visual acuity (BCVA), macular retinal sensitivity in the central 12 degrees, and optical coherence tomographic (OCT) findings were evaluated at baseline and at 1, 3, 6, and 12 months after the half-dose PDT. The integrities of the external limiting membrane (ELM), the inner segment/outer segment junction (IS/OS) line, and the cone outer segment tips (COST) line were determined. The retinal sensitivity was determined by MP-1 microperimetry.
RESULTS: The serous retinal detachment (SRD) was completely resolved in 11 eyes at 1 month and in 1 eye at 3 months. The remaining eye had a persistent SRD throughout the follow-up period. The mean retinal sensitivity was significantly better at 1, 3, 6, and 12 months after the half-dose PDT than at baseline. Before the PDT, 12 eyes had a continuous ELM and 1 eye had a fragmented ELM. The number of eyes with an intact IS/OS line and COST line increased with increasing post-PDT time. At 12 months after PDT, the IS/OS line was detected in 11 eyes and the COST line in 6 eyes. At 6 and 12 months, the retinal sensitivity was significantly higher in eyes with an intact COST line and IS/OS lines than in eyes with an intact IS/OS line only. However, no difference was found in the visual acuity of these 2 groups. The 1 eye with a persistent SRD and another eye with fragmented ELM and absent IS/OS and COST lines through the follow-up periods were associated with poor retinal sensitivity of 8.5 dB and 10.9 dB respectively.
CONCLUSIONS: Our findings show that there is a significant improvement in the macular sensitivity after half-dose PDT in eyes with chronic CSC. The improvement was correlated with the recovery of the IS/OS and COST lines at 6 and 12 months.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818904     DOI: 10.1016/j.ajo.2012.03.043

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  29 in total

1.  The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study.

Authors:  A Ozkaya; Z Alkin; M Ozveren; A T Yazici; M Taskapili
Journal:  Eye (Lond)       Date:  2016-04-22       Impact factor: 3.775

2.  Restoration of outer segments of foveal photoreceptors after resolution of malignant hypertensive retinopathy.

Authors:  Xiao-Qiang Liu; Xin-Rui Gao; Ding Xu; Chong Xu; Li-Ning Cao; Fang Wang
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

3.  Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.

Authors:  S H Karakus; B Basarir; E Y Pinarci; E U Kirandi; A Demirok
Journal:  Eye (Lond)       Date:  2013-03-22       Impact factor: 3.775

4.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

5.  Relationship between foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy.

Authors:  Taiji Hasegawa; Masahiro Okamoto; Naonori Masuda; Tetsuo Ueda; Nahoko Ogata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-31       Impact factor: 3.117

6.  Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.

Authors:  H W Chung; C M Yun; J T Kim; S-W Kim; J Oh; K Huh
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

7.  Dynamic changes and correlation analysis of outer retinal microstructure in macular area of central serous chorioretinopathy patients during restoration period.

Authors:  Chuangxin Huang; Lijun Zhou; Zhen Tian; Kunbei Lai; Xiaojing Zhong; Fabao Xu; Yajun Gong; Longhui Li; Chenjin Jin
Journal:  Int Ophthalmol       Date:  2021-01-08       Impact factor: 2.031

8.  Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy.

Authors:  Yong-Kyu Kim; Na-Kyung Ryoo; Se Joon Woo; Kyu Hyung Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-24       Impact factor: 3.117

9.  Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Helena Vasconcelos; Inês Marques; A Rita Santos; Pedro Melo; Isabel Pires; João Figueira; José Faria de Abreu; M Luz Cachulo; Rufino Silva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

10.  Structural and Functional Outcomes in Chronic Central Serous Chorioretinopathy Treated with Photodynamic Therapy.

Authors:  Pino Cidad; Eugenia González; Mónica Asencio; Jesús García
Journal:  Korean J Ophthalmol       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.